胃肠道超声内镜引导下细针穿刺活检评估妇科癌症疑似深部盆腔或腹部复发的可行性研究
回顾性队列研究纳入2010年1月至2017年12月本机构46例连续妇科癌症患者,影像怀疑深部盆腔或腹部复发,行超声内镜引导下细针穿刺(FNA)定位并活检。共66次操作,FNA可完成63例(94.5%),细胞学标本充足62/63(98.4%),确诊复发56例(90.3%)、排除6例(9.7%),无操作相关并发症。作者认为该技术微创、可行且安全,可用于确认妇科癌症盆腔/腹部复发。
要点
- 超声内镜引导FNA对妇科癌症疑似深部盆腔/腹部复发的组织学确认可行,FNA完成率94.5%。
- 细胞学标本充足率98.4%(62/63),复发确诊率90.3%(56例),排除率9.7%(6例)。
- 本组无操作相关并发症,病灶多位于腹膜后或累及肠道。
核心结论
- 超声内镜引导下FNA是微创、可行且安全的技术,可用于确认妇科癌症的盆腔/腹部复发。
研究设计与样本
- 回顾性队列研究,纳入2010年1月至2017年12月本机构46例连续妇科癌症患者,原发癌为卵巢癌22例、宫颈癌13例、子宫内膜癌4例、肉瘤4例、其他3例;均因超声、CT、PET-CT或MRI怀疑深部盆腔或腹部复发而接受超声内镜检查及FNA。
关键影像表现/征象
- 多数病灶位于腹膜后或累及肠道。
- 1例超声内镜未检出病灶,2例FNA未成功。
诊断标准与关键数值
- FNA可完成63例(94.5%)。
- 细胞学标本充足62/63(98.4%)。
- 复发确诊56例(90.3%),排除6例(9.7%)。
- 无操作相关并发症。
临床应用与阅片要点
- 对影像怀疑妇科癌症深部盆腔或腹部复发者,可考虑用超声内镜定位病灶并引导FNA行组织学确认。
- 病灶多位于腹膜后或累及肠道,阅片及操作时需关注这些部位。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To assess the feasibility of gastrointestinal endoscopic ultrasound (EUS)-guided fine-needle aspiration (FNA) for histologic confirmation of cancer recurrence in women with gynecologic cancer.
METHODS: This work was a retrospective cohort study comprising 46 consecutive women treated for gynecologic cancer and suspected of having a deep pelvic or abdominal recurrence on ultrasound imaging, computed tomography, positron emission tomography-computed tomography, or magnetic resonance imaging, evaluated at our institution from January 2010 to December 2017. Primary cancer was ovarian (n = 22), cervical (n = 13), endometrial (n = 4), sarcoma (n = 4), and other (n = 3). All women underwent EUS examinations for locating the lesion and guiding FNA. The results of FNA (benign/malignant) were assessed. Procedure-related complications were recorded.
RESULTS: The patients' mean age was 57.8 years. A total of 66 procedures were performed. Eleven women underwent 2 procedures; 2 women underwent 3 procedures; and 1 woman underwent 6 procedures at different times during the study period. In 1 case, no lesion was detected on the EUS assessment, and in 2 cases, FNA was not successful. Most lesions were located in the retroperitoneum or involved the intestine. Fine-needle aspiration could be performed in 63 cases (94.5%). Cytologic samples were adequate in 62 of 63 (98.4%). Recurrence was confirmed in 56 cases (90.3%) and ruled out in 6 (9.7%). No patient had any complication related to the procedure.
CONCLUSIONS: Endoscopic ultrasound-guided FNA is a minimally invasive, feasible, and safe technique for confirming pelvic/abdominal recurrence of gynecologic cancer.
引用
- Subtil JC, Alcázar JL, Betes MT, et al. Gastrointestinal Endoscopic Ultrasound-Guided Fine-Needle Aspiration for Assessing Suspected Deep Pelvic or Abdominal Recurrence in Gynecologic Cancer: A Feasibility Study. J Ultrasound Med. 2018. PMID: 30171619. doi:10.1002/jum.14766
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。